Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DISARM: Symbicort vs Advair effects on lung microbiota in COPD
NCT02833480Phase 2Unknown
- Sponsor
- University of British Columbia
- Start
- Feb 2015
- Primary completion
- Jan 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of budesonide, fluticasone propionate in chronic obstructive pulmonary disease (COPD), sponsored by University of British Columbia. Status: unknown.
02
Drugs
budesonidefluticasone propionate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02833480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02833480.